Open access peer-reviewed chapter

The Bevacizumab “Pseudoresponse” in Glioma: Disappointment or Opportunity?

By Piia Thomas, Daniel Spielman and Lawrence Recht

Submitted: November 4th 2010Reviewed: May 10th 2011Published: August 23rd 2011

DOI: 10.5772/19845

Downloaded: 1431

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike-3.0 License, which permits use, distribution and reproduction for non-commercial purposes, provided the original is properly cited and derivative works building on this content are distributed under the same license.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Piia Thomas, Daniel Spielman and Lawrence Recht (August 23rd 2011). The Bevacizumab “Pseudoresponse” in Glioma: Disappointment or Opportunity?, Brain Tumors Ana Lucia Abujamra, IntechOpen, DOI: 10.5772/19845. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/brain-tumors-current-and-emerging-therapeutic-strategies/the-bevacizumab-pseudoresponse-in-glioma-disappointment-or-opportunity-" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1431total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

The Molecular Mechanism for Differentiation Therapy of Malignant Glioma

By Wenbo Zhu and Guangmei Yan

Related Book

First chapter

Patient-Reported Outcome Monitoring in Brain Tumour Patients: Benefits and Requirements

By Lisa M. Wintner, Johannes M. Giesinger and Bernhard Holzner

We are IntechOpen, the first native scientific publisher of Open Access books. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,350 Open Access Books

+57,400 Citations in Web of Science

+107,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us